Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (ADACEL®) in Persons ≥65 Years of Age.
Phase of Trial: Phase IV
Latest Information Update: 18 Oct 2012
At a glance
- Drugs DTaP vaccine (Primary) ; Diphtheria-tetanus vaccine
- Indications Diphtheria; Pertussis; Tetanus
- Focus Pharmacodynamics
- Sponsors Sanofi
- 10 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Sep 2009 Actual end date (Nov 2008) added as reported by ClinicalTrials.gov.
- 23 Jun 2008 New trial record.